Androgen Society Position Paper on Cardiovascular Risk With Testosterone Therapy
The Androgen Society is an international, multidisciplinary medical organization committed to advancing research and education in the field of testosterone deficiency and testosterone therapy (TTh). This position paper is written in response to results of the TRAVERSE study, published in June 2023, which reported no increased risk of major adverse cardiovascular events (MACE) in men who received TTh compared with placebo.In 2013-2014, 2 observational studies reported increased cardiovascular (CV) risks with TTh and received wide media attention.
